Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 24, Issue 9, pp. 2116-2127
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 16, 2017
- Revision received December 21, 2017
- Accepted February 19, 2018
- Published first February 23, 2018.
Article Versions
- Previous version (February 23, 2018 - 06:54).
- Previous version (March 27, 2018 - 08:40).
- Previous version (April 5, 2018 - 11:04).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Jennifer Haynes1,
- Trevor D. McKee1,2,
- Andrew Haller1,
- Yadong Wang1,
- Cherry Leung1,
- Deena M.A. Gendoo1,3,
- Evelyne Lima-Fernandes4,
- Antonija Kreso1,
- Robin Wolman1,
- Eva Szentgyorgyi5,
- Douglass C. Vines1,2,6,
- Benjamin Haibe-Kains1,3,7,
- Bradly G. Wouters1,3,6,
- Ur Metser1,8,9,
- David A. Jaffray1,2,3,6,9,
- Myles Smith10, and
- Catherine A. O'Brien1,11,12,13,*
- 1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- 2STTARR Innovation Centre, University Health Network, Toronto, Ontario, Canada.
- 3Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
- 4Structural Genomics Consortium, Toronto, Ontario, Canada.
- 5Department of Pathology, University Health Network, Toronto, Ontario, Canada.
- 6Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
- 7Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
- 8Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
- 9Techna Institute for the Advancement of Technology for Health, University Health Network, Toronto, Ontario, Canada.
- 10Department of Surgery, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.
- 11Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- 12Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
- 13Department of Surgery, University Health Network, Toronto, Ontario, Canada.
- ↵*Corresponding Author:
Catherine A. O'Brien, Princess Margaret Cancer Research Tower, 101 College St, Room 13-704, Toronto, ON M5G 1L7, Canada. Phone: 416-581-7537; Fax: 416-340-3808; E-mail: Catherine.OBrien{at}uhnresearch.ca
May 2018
Volume 24, Issue 9
Volume 24, Issue 9
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer
Jump to section
Advertisement